Author:
Agarwal Rajesh,Biswas Debabani,Kundu Susmita,Paul Suman,Hariprasath K.,Ghosh Saswata
Publisher
Jaypee Brothers Medical Publishing
Reference28 articles.
1. 1. Cappelli S, Guiducci S, Randone SB, Cerinic MM. Immunosuppression for interstitial lung disease in systemic sclerosis. Eur Respir Rev 2013;22:236–43.
2. 2. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283–9.
3. 3. Mayes MD, Reveille JD. Epidemiology, demographics, and genetics. In: Clements PJ, Furst DE, editors Systemic Sclerosis; 2nd edition. New York: Lippincott, Williams and Wilkins; 2004:pp1–15.
4. 4. Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993;20:834–44.
5. 5. Akesson A, Scheja A, Lundin A, Wollheim F. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 1994;37:729–35.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献